HRI reviews colchicine for cardiovascular disease
HRI scientists and collaborators have reviewed colchicine and its potential as a treatment for cardiovascular disease, in a paper published in Heart, Lung and Circulation.
Solving a sticky problem in diabetes: Dr Lining (Arnold) Ju wins Ideas Grant
Congratulations to Dr Lining (Arnold) Ju on being awarded a 2020 Ideas Grant from the NHMRC for his project Novel ‘Mechano-medicine’ combats deadly sticky blood clots in diabetes.
Dr Jessica Orchard wins CSANZ Prevention Prize
HRI's Dr Jessica Orchard was awarded the Prevention Prize at the Cardiac Society of Australia & New Zealand conference for her talk on the AF-SMART II rural screening study.
HRI wins Best Workplace Award 2020
HRI has won ‘Best Workplace 2020’ for providing an exceptional work environment for staff, awarded by consultancy firm Voice Project.
HRI researchers take steps to prevent peripheral artery disease
HRI’s Arterial Inflammation and Redox Biology Group has made an important discovery in preventing peripheral artery disease.
Deadly Steps lead to a healthier heart
HRI’s love of ‘everything science’ and desire to spread the enthusiasm to the next generation has seen major steps in Deadly Science’s latest initiative.
Global media interest in HRI’s breakthrough anti-clotting drug for COVID-19
The revolutionary new anti-clotting medicine developed by HRI has attracted global media interest due to its far-reaching impact.
HRI’s Kiwi Summer Scholars shine
Seven impressive young scholars from New Zealand recently joined HRI for almost two months of hands-on experience in world-class research facilities.
HRI welcomes Dr Xuyu Liu
HRI is pleased to welcome Dr Xuyu (John) Liu as Unit Leader.